Compile Data Set for Download or QSAR
Report error Found 59 Enz. Inhib. hit(s) with all data for entry = 11462
TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617767(5-(4-((2-(2-fluoroethoxy)ethyl)amino)benzy lidene)...)
Affinity DataIC50: 450nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617766(3-hexyl-1-methyl-5-(4-morpholinobenzylidene)-2-sel...)
Affinity DataIC50: 500nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617762(5-(2,4-dihydroxybenzylidene)-3-hexyl-1-methyl-2-se...)
Affinity DataIC50: 680nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617756(5-(3,5-dihydroxybenzylidene)-1-methyl-3-phenethyl-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617758(3-cyclohexyl-5-(2,4-dihydroxybenzylidene)-1-methyl...)
Affinity DataIC50: 1.00E+3nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617741(5-(4-((2-(2-hydroxyethoxy)ethyl)amino)benz ylidene...)
Affinity DataIC50: 2.30E+3nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617776(5-(2,4-dihydroxybenzylidene)-1-methyl-3-pentyl-2-s...)
Affinity DataIC50: 2.90E+3nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617768(3-cyclopentyl-5-(2,4-dihydroxybenzylidene)-1-methy...)
Affinity DataIC50: 3.00E+3nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617757(1-methyl-5-(4-morpholinobenzylidene)-3-phenethyl-2...)
Affinity DataIC50: 3.50E+3nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617765(5-(3,5-dihydroxybenzylidene)-3-hexyl-1-methyl-2-se...)
Affinity DataIC50: 5.00E+3nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617773(5-(4-chlorobenzylidene)-1-methyl-3-(3-morpholinopr...)
Affinity DataIC50: 5.00E+3nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617742(1-methyl-5-(4-((2-morpholinoethyl)amino)benzylid e...)
Affinity DataIC50: 5.20E+3nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617763(5-(2,3-dihydroxybenzylidene)-3-hexyl-1-methyl-2-se...)
Affinity DataIC50: 6.00E+3nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617744(5-(3,5-dihydroxybenzylidene)-3-(4-ethylphenyl)-1-m...)
Affinity DataIC50: 9.00E+3nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617754(5-(2,4-dihydroxybenzylidene)-1-methyl-3-phenethyl-...)
Affinity DataIC50: 9.80E+3nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617745(3-(4-ethylphenyl)-1-methyl-5-(4-(piperidine-1-yl)b...)
Affinity DataIC50: 1.10E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617746(5-(4-bromobenzylidene)-3-(4-ethylphenyl)-1-methyl-...)
Affinity DataIC50: 1.10E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617738(1-methyl-5-(4-pyrrolidine-1-yl)benzylidene-2-selen...)
Affinity DataIC50: 1.10E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617736(1-methyl-5-(4-piperidine-1-yl)benzylidene-3-(4-tol...)
Affinity DataIC50: 1.10E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617739(5-(4-hydroxybenzylidene)-1-methyl-2-selenoxo-3-(4-...)
Affinity DataIC50: 1.30E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617775(5-(2,4-dihydroxybenzylidene)-3-(5-fluoropentyl)-1-...)
Affinity DataIC50: 1.30E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617743(5-(2,4-dihydroxybenzylidene)-3-(4-ethylphenyl)-1-m...)
Affinity DataIC50: 1.40E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617769(3-cyclopentyl-5-(2,3-dihydroxybenzylidene)-1-methy...)
Affinity DataIC50: 1.40E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617731(1-methyl-3-phenyl-5-(4-pyrrolidine-1-yl)benzyliden...)
Affinity DataIC50: 1.60E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617761(3-cyclohexyl-5-(3,5-dihydroxybenzylidene)-1-methyl...)
Affinity DataIC50: 1.80E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617774(5-(3,5-dihydroxybenzylidene)-3-(5-fluorohexyl)-1-m...)
Affinity DataIC50: 1.80E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617759(3-cyclohexyl-5-(2,3-dihydroxybenzylidene)-1-methyl...)
Affinity DataIC50: 1.80E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617750(3-(4-chlorophenyl)-5-(3,4-dihydroxybenzylidene)-1-...)
Affinity DataIC50: 2.00E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617728(5-(2,4-dihydroxybenzylidene)-1-methyl-3-phenyl-2-s...)
Affinity DataIC50: 2.00E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617777(5-(2,4-dihydroxybenzylidene)-1-ethyl-3-phenyl-2-se...)
Affinity DataIC50: 2.20E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617784(1-benzyl-5-(2,4-dihydroxybenzylidene)-3-(4-ethylph...)
Affinity DataIC50: 2.20E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617755(5-(4-(dimethylamino)benzylidene)-1-methyl-3-phenet...)
Affinity DataIC50: 2.30E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617772(5-(4-(dimethylamino)benzylidene-3-(4-fluorophenyl)...)
Affinity DataIC50: 2.30E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617781(1-benzyl-5-(2,3-dihydroxybenzylidene)-3-phenyl-2-s...)
Affinity DataIC50: 2.30E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617783(1-benzyl-5-(3,5-dihydroxybenzylidene)-3-phenyl-2-s...)
Affinity DataIC50: 2.30E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617786(1-benzyl-5-(3,5-dihydroxybenzylidene)-3-(4-ethylph...)
Affinity DataIC50: 2.30E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617771(3-cyclopentyl-5-(3,4-dihydroxybenzylidene)-1-methy...)
Affinity DataIC50: 2.60E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617729(5-(4-(dimethylamino)benzylidene)-1-methyl-3-phenyl...)
Affinity DataIC50: 2.60E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617770(3-cyclopentyl-5-(4-(dimethylamino)benzylidene)-1-m...)
Affinity DataIC50: 2.60E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617787(1-benzyl-3-(4-chlorophenyl)-5-(2,3-dihydroxybenzyl...)
Affinity DataIC50: 2.60E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617752(3-(4-chlorophenyl)-1-methyl-5-(pyridine-3-ylmethyl...)
Affinity DataIC50: 2.70E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617785(1-benzyl-5-(3,4-dihydroxybenzylidene)-3-(4-ethylph...)
Affinity DataIC50: 2.90E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617747(3-(4-ethylphenyl)-1-methyl-5-(pyridine-3-ylmethyle...)
Affinity DataIC50: 3.00E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617788(1-benzyl-3-(4-chlorophenyl)-5-(3,4-dihydroxybenzyl...)
Affinity DataIC50: 3.10E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617748(3-(4-chlorophenyl)-5-(2,4-dihydroxybenzylidene)-1-...)
Affinity DataIC50: 3.10E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617764(5-(4-(dimethylamino)benzylidene)-3-hexyl-1-methyl-...)
Affinity DataIC50: 3.30E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617782(1-benzyl-5-(3,4-dihydroxybenzylidene)-3-phenyl-2-s...)
Affinity DataIC50: 3.40E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617733(1-methyl-3-phenyl-5-(pyridine-3-ylmethylene)-2-sel...)
Affinity DataIC50: 3.70E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617780(1-ethyl-3-(4-ethylphenyl)-5-(4-pyrrolidine-1-yl)be...)
Affinity DataIC50: 4.00E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

TargetNADPH oxidase 1(Human)
Duksung Women''S University Industry-Academic Cooperation Foundation

US Patent
LigandPNGBDBM617732(5-(3-hydroxybenzylidene)-1-methyl-3-phenyl-2-selen...)
Affinity DataIC50: 4.10E+4nMAssay Description:Specifically, for the evaluation of compound activity, 0.1 mM of the compound was added to a minimum medium (MM20) spore suspension diluted to ⅕...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
Go to US Patent

Displayed 1 to 50 (of 59 total ) | Next | Last >>
Jump to: